Literature DB >> 8344392

Differential subcellular distribution of mortalin in mortal and immortal mouse and human fibroblasts.

R Wadhwa1, S C Kaul, Y Mitsui, Y Sugimoto.   

Abstract

Mortalin, p66mot-1, from the cytosolic fractions of mouse embryonic fibroblasts (MEF) has been identified. We have cloned and characterized it as a novel member of mouse hsp70 family [R. Wadhwa, S. C. Kaul, Y. Ikawa, and Y. Sugimoto (1993) J. Biol. Chem. 268, 6615-6621]. We report that immortal clones from MEF such as NIH 3T3, RS4, and Balb/c 3T3 harbor the same or a very similar protein but in the perinuclear locale. Biochemical analysis revealed that the proteins from mortal (MEF) and immortal (NIH 3T3) fibroblasts do not show gross differences. However, the phenomenon of differential distribution of p66 protein in mortal and immortal fibroblasts is conserved in three different strains of mouse and, interestingly, in human fibroblasts, too. The data suggest that at least one common step is involved in immortalization of mouse and human fibroblasts and also point to the practical implication(s) of such easily detectable differences.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344392     DOI: 10.1006/excr.1993.1213

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

1.  Identification and characterization of molecular interactions between glucose-regulated proteins (GRPs) mortalin/GRP75/peptide-binding protein 74 (PBP74) and GRP94.

Authors:  S Takano; R Wadhwa; Y Mitsui; S C Kaul
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes.

Authors:  M J Bertram; N G Bérubé; X Hang-Swanson; Q Ran; J K Leung; S Bryce; K Spurgers; R J Bick; A Baldini; Y Ning; L J Clark; E K Parkinson; J C Barrett; J R Smith; O M Pereira-Smith
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 3.  An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?

Authors:  Renu Wadhwa; Kazunari Taira; Sunil C Kaul
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

4.  Overproduction and biophysical characterization of human HSP70 proteins.

Authors:  Rebba C Boswell-Casteel; Jennifer M Johnson; Kelli D Duggan; Yuko Tsutsui; Franklin A Hays
Journal:  Protein Expr Purif       Date:  2014-09-27       Impact factor: 1.650

Review 5.  A review of multi-domain and flexible molecular chaperones studies by small-angle X-ray scattering.

Authors:  Júlio C Borges; Thiago V Seraphim; Paulo R Dores-Silva; Leandro R S Barbosa
Journal:  Biophys Rev       Date:  2016-03-04

6.  Identification and characterization of molecular interactions between mortalin/mtHsp70 and HSP60.

Authors:  Renu Wadhwa; Syuichi Takano; Kamaljit Kaur; Satoshi Aida; Tomoko Yaguchi; Zeenia Kaul; Takashi Hirano; Kazunari Taira; Sunil C Kaul
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

7.  Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy.

Authors:  Sanam Sane; Ammara Abdullah; Morgan E Nelson; Hongmin Wang; Subhash C Chauhan; Samuel S Newton; Khosrow Rezvani
Journal:  Cell Stress Chaperones       Date:  2015-12-04       Impact factor: 3.667

8.  Tinospora cordifolia Induces Differentiation and Senescence Pathways in Neuroblastoma Cells.

Authors:  Rachana Mishra; Gurcharan Kaur
Journal:  Mol Neurobiol       Date:  2014-10-04       Impact factor: 5.590

9.  PBP74, a new member of the mammalian 70-kDa heat shock protein family, is a mitochondrial protein.

Authors:  J N Dahlseid; R Lill; J M Green; X Xu; Y Qiu; S K Pierce
Journal:  Mol Biol Cell       Date:  1994-11       Impact factor: 4.138

10.  Water extract of ashwagandha leaves limits proliferation and migration, and induces differentiation in glioma cells.

Authors:  Hardeep Kataria; Navjot Shah; Sunil C Kaul; Renu Wadhwa; Gurcharan Kaur
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-14       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.